Nestin expression throughout multistep pathogenesis of multiple myeloma

British Journal of Haematology

Volumn 164, Issue 5, 2014, Pages 701-709

  Svachova, Hana ^a   Kryukov, Fedor ^a   Kryukova, Elena ^a   Sevcikova, Sabina ^a   Nemec, Pavel ^a   Greslikova, Henrieta ^a   Rihova, Lucie ^a,b   Kubiczkova, Lenka ^a   Hajek, Roman ^a,c  

^a MASARYK UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^c UNIVERSITY HOSPITAL OSTRAVA   (Czech Republic)

Author keywords

Flow cytometry; Monoclonal gammopathy; Multiple myeloma; Nestin; Stem cells

Indexed keywords

FLOW CYTOMETRY; MONOCLONAL GAMMOPATHY; MULTIPLE MYELOMA; NESTIN; STEM CELLS;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, PLASMA CELL; MALE; MIDDLE AGED; MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE; MULTIPLE MYELOMA; NEOPLASM PROTEINS; NEOPLASM STAGING; NESTIN; PROGNOSIS; RECURRENCE; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84894028355     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12689     Document Type: Article

References (53)

1. Allan, A.L. (2011) Cancer Stem Cells in Solid Tumors. Stem Cell Biology and Regenerative Medicine. Humana Press, New York, NY.
2. Bataille, R., Pellat-Deceunynck, C., Robillard, N., Avet-Loiseau, H., Harousseau, J.L. & Moreau, P. (2008) CD117 (c-kit) is aberrantly expressed in a subset of MGUS and multiple myeloma with unexpectedly good prognosis. Leukemia Research, 32, 379-382.
3. Bergsagel, P.L., Masellis Smith, A., Belch, A.R. & Pilarski, L.M. (1995) The blood B-cells and bone marrow plasma cells in patients with multiple myeloma share identical IgH rearrangements. Current Topics in Microbiology and Immunology, 194, 17-24.
4. Cheng, L., Jin, Z., Liu, L., Yan, Y., Li, T., Zhu, X. & Jing, N. (2004) Characterization and promoter analysis of the mouse nestin gene. FEBS Letters, 565, 195-202.
5. Chesi, M., Robbiani, D.F., Sebag, M., Chng, W.J., Affer, M., Tiedemann, R., Valdez, R., Palmer, S.E., Haas, S.S., Stewart, A.K., Fonseca, R., Kremer, R., Cattoretti, G. & Bergsagel, P.L. (2008) AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies. Cancer Cell, 13, 167-180.
6. Chiron, D., Surget, S., Maïga, S., Bataille, R., Moreau, P., Le Gouill, S., Amiot, M. & Pellat- Deceunynck, C. (2012) The peripheral CD138+ population but not the CD138- population contains myeloma clonogenic cells in plasma cell leukaemia patients. British Journal of Haematology, 156, 679-683.
7. Chng, W.J., Huang, G.F., Chung, T.H., Ng, S.B., Gonzalez-Paz, N., Troska-Price, T., Mulligan, G., Chesi, M., Bergsagel, P.L. & Fonseca, R. (2011) Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma. Leukemia, 25, 1026-1035.
8. Dhodapkar, M.V. & Dhodapkar, K.M. (2011) Spontaneous and therapy-induced immunity to pluripotency genes in humans: clinical implications, opportunities and challenges. Cancer Immunology, Immunotherapy, 60, 413-418.
9. Drexler, H.G. & Matsuo, Y. (2000) Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia. Leukemia Research, 24, 681-703.
10. Durie, B.G., Harousseau, J.L., Miguel, J.S., Bladá, J., Barlogie, B., Anderson, K., Gertz, M., Dimopoulos, M., Westin, J., Sonneveld, P., Ludwig, H., Gahrton, G., Beksac, M., Crowley, J., Belch, A., Boccadaro, M., Cavo, M., Turesson, I., Joshua, D., Vesole, D., Kyle, R., Alexanian, R., Tricot, G., Attal, M., Merlini, G., Powles, R., Richardson, P., Shimizu, K., Tosi, P., Morgan, G., Rajkumar, S.V. & International Myeloma Working Group. (2006) International uniform response criteria for multiple myeloma. Leukemia, 20, 1467-1473.
11. Ehrmann, J., Kolár, Z. & Mokry, J. (2005) Nestin as a diagnostic and prognostic marker: immunohistochemical analysis of its expression in different tumours. Journal of Clinical Pathology, 58, 222-223.
12. Fonseca, R., Barlogie, B., Bataille, R., Bastard, C., Bergsagel, P.L., Chesi, M., Davies, F.E., Drach, J., Greipp, P.R., Kirsch, I.R., Kuehl, W.M., Hernandez, J.M., Minvielle, S., Pilarski, L.M., Shaughnessy, J.D., Stewart, A.K. & Avet-Loiseau, H. (2004) Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Research, 64, 1546-1558.
13. Greslikova, H., Zaoralova, R., Filkova, H., Nemec, P., Oltova, A., Kupska, R., Rudolecka, P., Smetana, J., Pour, L., Zahradova, L., Krejci, M., Buchler, T., Adam, Z., Hajek, R. & Kuglik, P. (2010) Negative prognostic significance of two or more cytogenetic abnormalities in multiple myeloma patients treated with autologous stem cell transplantation. Neoplasma, 57, 111-117.
14. Han, D.W., Do, J.T., Araúzo-Bravo, M.J., Lee, S.H., Meissner, A., Lee, H.T., Jaenisch, R. & Schöler, H.R. (2009) Epigenetic hierarchy governing Nestin expression. Stem Cells, 27, 1088-1097.
15. Hanamura, I., Stewart, J.P., Huang, Y., Zhan, F., Santra, M., Sawyer, J.R., Hollmig, K., Zangarri, M., Pineda-Roman, M., van Rhee, F., Cavallo, F., Burington, B., Crowley, J., Tricot, G., Barlogie, B. & Shaughnessy, J.D. (2006) Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stemcell transplantation. Blood, 108, 1724-1732.
16. Hockfield, S. & McKay, R.D. (1985) Identification of major cell classes in the developing mammalian nervous system. Journal of Neuroscience, 5, 3310-3328.
17. Huang, Y.L., Shi, G.Y., Jiang, M.J., Lee, H., Chou, Y.W., Wu, H.L. & Yang, H.Y. (2008) Epidermal growth factor up-regulates the expression of nestin through the Ras-Raf-ERK signaling axis in rat vascular smooth muscle cells. Biochemical and Biophysical Research Communications, 377, 361-366.
18. Ishiwata, T., Matsuda, Y. & Naito, Z. (2011) Nestin in gastrointestinal and other cancers: effects on cells and tumor angiogenesis. World Journal of Gastroenterology, 17, 409-418.
19. Jensen, G.S., Belch, A.R., Mant, M.J., Ruether, B.A., Yacyshyn, B.R. & Pilarski, L.M. (1993) Expression of multiple beta 1 integrins on circulating monoclonal B cells in patients with multiple myeloma. American Journal of Hematology, 43, 29-36.
20. Jungbluth, A.A., Ely, S., DiLiberto, M., Niesvizky, R., Williamson, B., Frosina, D., Chen, Y.T., Bhardwaj, N., Chen-Kiang, S., Old, L.J. & Cho, H.J. (2005) The cancer-testis antigens CT7 (MAGE-C1) and MAGE-A3/6 are commonly expressed in multiple myeloma and correlate with plasma-cell proliferation. Blood, 106, 167-174.
21. Kachinsky, A.M., Dominov, J.A. & Miller, J.B. (1995) Intermediate filaments in cardiac myogenesis: nestin in the developing mouse heart. Journal of Histochemistry and Cytochemistry, 43, 843-847.
22. Kleeberger, W., Bova, G.S., Nielsen, M.E., Herawi, M., Chuang, A.Y., Epstein, J.I. & Berman, D.M. (2007) Roles for the stem cell associated intermediate filament Nestin in prostate cancer migration and metastasis. Cancer Research, 67, 9199-9206.
23. Kovarova, L., Varmuzová, T., Zarbochová, P., Suská, R., Muthu Raja, K.R., Stossová, J., Penka, M. & Hájek, R. (2011) Flow cytometry in monoclonal gammopathies. Klin Onkol, 24, S24-S29.
24. Krupkova, O., Loja, T., Zambo, I. & Veselska, R. (2010) Nestin expression in human tumors and tumor cell lines. Neoplasma, 57, 291-298.
25. Kumar, S., Witzig, T.E., Timm, M., Haug, J., Wellik, L., Kimlinger, T.K., Greipp, P.R. & Rajkumar, S.V. (2004) Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression. Blood, 104, 1159-1165.
26. Lendahl, U., Zimmerman, L.B. & McKay, R.D. (1990) CNS stem cells express a new class of intermediate filament protein. Cell, 60, 585-595.
27. Liu, S., Otsuyama, K., Ma, Z., Abroun, S., Shamsasenjan, K., Amin, J., Asaoku, H. & Kawano, M.M. (2007) Induction of multilineage markers in human myeloma cells and their down-regulation by interleukin 6. International Journal of Hematology, 85, 49-58.
28. Mani, S.A., Guo, W., Liao, M.J., Eaton, E.N., Ayyanan, A., Zhou, A.Y., Brooks, M., Reinhard, F., Zhang, C.C., Shipitsin, M., Campbell, L.L., Polyak, K., Brisken, C., Yang, J. & Weinberg, R.A. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell, 133, 704-715.
29. Matsui, W., Huff, C.A., Wang, Q., Malehorn, M.T., Barber, J., Tanhehco, Y., Smith, B.D., Civin, C.I. & Jones, R.J. (2004) Characterization of clonogenic multiple myeloma cells. Blood, 103, 2332-2336.
30. Means, A.L., Meszoely, I.M., Suzuki, K., Miyamoto, Y., Rustgi, A.K., Coffey, R.J., Wright, C.V., Stoffers, D.A. & Leach, S.D. (2005) Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestinpositive intermediates. Development, 132, 3767-3776.
31. Pilarski, L.M., Hipperson, G., Seeberger, K., Pruski, E., Coupland, R.W. & Belch, A.R. (2000) Myeloma progenitors in the blood of patients with aggressive or minimal disease: engraftment and self-renewal of primary human myeloma in the bone marrow of NOD SCID mice. Blood, 95, 1056-1065.
32. Prindull, G. & Zipori, D. (2004) Environmental guidance of normal and tumor cell plasticity: epithelial mesenchymal transitions as a paradigm. Blood, 103, 2892-2899.
33. Rajkumar, S.V. & Kyle, R.A. (2005) Multiple myeloma: diagnosis and treatment. Mayo Clinic Proceedings, 80, 1371-1382.
34. Rasmussen, T., Jensen, L. & Johnsen, H.E. (2000) Levels of circulating CD19 + cells in patients with multiple myeloma. Blood, 95, 4020-4021.
35. Reimer, R., Helmbold, H., Szalay, B., Hagel, C., Hohenberg, H., Deppert, W. & Bohn, W. (2009) Nestin modulates glucocorticoid receptor function by cytoplasmic anchoring. PLoS ONE, 4, e6084.
36. Richardson, P. & Anderson, K. (2006) Thalidomide and dexamethasone: a new standard of care for initial therapy in multiple myeloma. Journal of Clinical Oncology, 24, 334-336.
37. Sahlgren, C.M., Pallari, H.M., He, T., Chou, Y.H., Goldman, R.D. & Eriksson, J.E. (2006) A nestin scaffold links Cdk5/p35 signaling to oxidantinduced cell death. EMBO Journal, 25, 4808- 4819.
38. Schmidt-Hieber, M., Pérez-Andrés, M., Paiva, B., Flores-Montero, J., Perez, J.J., Gutierrez, N.C., Vidriales, M.B., Matarraz, S., San Miguel, J.F. & Orfao, A. (2011) CD117 expression in gammopathies is associated with an altered maturation of the myeloid and lymphoid hematopoietic cell compartments and favorable disease features. Haematologica, 96, 328-332.
39. Sevcikova, S., Nemec, P., Pour, L. & Hájek, R. (2011) Genomics in multiple myeloma research. Klin Onkol, 24, S34-S38.
40. Spisek, R., Kukreja, A., Chen, L.C., Matthews, P., Mazumder, A., Vesole, D., Jagannath, S., Zebroski, H.A., Simpson, A.J., Ritter, G., Durie, B., Crowley, J., Shaughnessy, J.D., Scanlan, M.J., Gure, A.O., Barlogie, B. & Dhodapkar, M.V. (2007) Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy. Journal of Experimental Medicine, 204, 831-840.
41. Steinert, P.M., Chou, Y.H., Prahlad, V., Parry, D.A., Marekov, L.N., Wu, K.C., Jang, S.I. & Goldman, R.D. (1999) A high molecular weight intermediate filament-associated protein in BHK-21 cells is nestin, a type VI intermediate filament protein. Limited co-assembly in vitro to form heteropolymers with type III vimentin and type IV alpha-internexin. Journal of Biological Chemistry, 274, 9881-9890.
42. van Stijn, A., Kok, A., van der Pol, M.A., Feller, N., Roemen, G.M., Westra, A.H., Ossenkoppele, G.J. & Schuurhuis, G.J. (2003) Multiparameter flow cytometric quantification of apoptosisrelated protein expression. Leukemia, 17, 787-788.
43. Svachova, H., Pour, L., Sana, J., Kovarova, L., Raja, K.R. & Hajek, R. (2011a) Stem cell marker nestin is expressed in plasma cells of multiple myeloma patients. Leukemia Research, 35, 1008-1013.
44. Svachova, H., Kovárová, L., Stossová, J., Potácová, A., Pour, L. & Hájek, R. (2011b) Impact of nestin analysis in multiple myeloma. Klin Onkol, 24, S53-S57.
45. Szczepek, A.J., Bergsagel, P.L., Axelsson, L., Brown, C.B., Belch, A.R. & Pilarski, L.M. (1997) CD34 + cells in the blood of patients with multiple myeloma express CD19 and IgH mRNA and have patient-specific IgH VDJ gene rearrangements. Blood, 89, 1824-1833.
46. Vaittinen, S., Lukka, R., Sahlgren, C., Hurme, T., Rantanen, J., Lendahl, U., Eriksson, J.E. & Kalimo, H. (2001) The expression of intermediate filament protein nestin as related to vimentin and desmin in regenerating skeletal muscle. Journal of Neuropathology and Experimental Neurology, 60, 588-597.
47. Veselska, R., Kuglik, P., Cejpek, P., Svachova, H., Neradil, J., Loja, T. & Relichova, J. (2006) Nestin expression in the cell lines derived from glioblastoma multiforme. BMC Cancer, 6, 32.
48. Wiese, C., Rolletschek, A., Kania, G., Blyszczuk, P., Tarasov, K.V., Tarasova, Y., Wersto, R.P., Boheler, K.R. & Wobus, A.M. (2004) Nestin expression - a property of multi-lineage progenitor cells? Cellular and Molecular Life Sciences, 61, 2510-2522.
49. Yaccoby, S. (2005) The phenotypic plasticity of myeloma plasma cells as expressed by dedifferentiation into an immature, resilient, and apoptosis- resistant phenotype. Clinical Cancer Research, 11, 7599-7606.
50. Yamada, H., Takano, T., Ito, Y., Matsuzuka, F., Miya, A., Kobayashi, K., Yoshida, H., Watanabe, M., Iwatani, Y. & Miyauchi, A. (2009) Expression of nestin mRNA is a differentiation marker in thyroid tumors. Cancer Letters, 280, 61-64.
51. Yata, K. & Yaccoby, S. (2004) The SCID-rab model: a novel in vivo system for primary human myeloma demonstrating growth of CD138-expressing malignant cells. Leukemia, 18, 1891-1897.
52. Zhu, L., Somlo, G., Zhou, B., Shao, J., Bedell, V., Slovak, M.L., Liu, X., Luo, J. & Yen, Y. (2005) Fibroblast growth factor receptor 3 inhibition by short hairpin RNAs leads to apoptosis in multiple myeloma. Molecular Cancer Therapeutics, 4, 787-798.
53. Zimmerman, L., Parr, B., Lendahl, U., Cunningham, M., McKay, R., Gavin, B., Mann, J., Vassileva, G. & McMahon, A. (1994) Independent regulatory elements in the nestin gene direct transgene expression to neural stem cells or muscle precursors. Neuron, 12, 11-24.